1) AAA microcapsule
AAA微囊
2) microcapsule
['maikrəu,kæpsju:l]
微囊
1.
Progress in preparation and biomedical application of porous poly(2-hydroxyethyl methacrylate) microspheres and microcapsules;
PHEMA多孔微球和微囊的制备及生物医药应用进展
2.
Optimization of Technology for Avermectins Microcapsule by Uniform Design;
均匀设计优选阿维菌素微囊的制备工艺
3.
Preparation of amoxicillin microcapsules by using solution enhanced dispersion of supercritical fluids process;
超临界流体增强溶液分散度法制备阿莫西林缓释微囊
3) microencapsulation
微囊
1.
The effects of temperature, pressure, liquid solution concentration, and stirring rate on thephysical characteristics of ethyl cellulose microencapsulations were studied.
利用超临界CO2抗溶剂法从乙基纤维素和丙酮溶液中制得了乙基纤维素微囊,考察了温度、压力、溶液浓度和搅拌速度等工艺参数对物性的影响,试验结果表明:超临界CO2抗溶剂法可用于食品材料的微囊制粒,所得乙基纤维素微囊的粒径在2。
2.
Objective To investigate the in vitro proliferation and microencapsulation of ovarian cells.
目的探讨微囊化制备在卵巢细胞体外增殖培养研究中的作用。
3.
Alginate-polylysine-alginate microencapsulation is the most successful microencapsulation, but microencapsulation which is made up of alginate crosslinked with BaCl2 without a traditional permselective component has been supported by many researchers.
微囊移植技术能起有效的免疫隔离作用,为解决排斥反应、供体缺乏等问题提供了新思路。
4) Microcapsules
微囊
1.
Formula Optimization of Aspirin Chitosan-Sodium Alginate Microcapsules and Drug Releasing Mechanism Study;
阿司匹林壳聚糖-海藻酸钠微囊处方优化与释药机制研究
2.
Preparation and quality check of Oleanolic acid microcapsules;
齐墩果酸微囊的制备及质量考察
3.
Influencing factors on dampproof effect of microcapsules and study on mechanism;
微囊防潮效果影响因素及其机制探讨
5) Microencapsulate
[,maikrəuin'kæpsjuleit]
微囊
1.
The Effect of Microencapsulated NGF-expressing NIH-3T3 Cells on Bioengineered Dermis Function In Vitro;
微囊化NGF基因修饰NIH3T3细胞对体外培养的组织工程皮肤功能的影响
2.
Microencapsulated pig hepatocytes transplantation in the treatment of acute liver failure in rats;
微囊化猪肝细胞移植治疗大鼠急性肝衰竭
3.
Development of transplantation of microencapsulated genetic modified cells;
微囊化基因修饰细胞移植技术的发展
6) AAA bone
AAA骨
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条